US$ 28.16
bpc 157 human clinical trials safety bpc-157 evidence review regulatory status BPC‑157 — 10 mg bpc-157 human clinical trials evidence
Description
Inhibits NNMT, elevates NAD+, enhances fatty acid oxidation, reduces fat accumulation and lipotoxicity

Taxes will be added at the register

Guidelines for the Safe Preparation of Sterile Compounds: Results of the ISMP Sterile Preparation Compounding Safety Summit of October 2011
If a product is classified as a medicine and is not appropriately authorised, we are able to take action to ensure regulatory compliance, including the removal of the product from the UK market where necessary

sodium chloride, water for injections
